Steroid-induced hyperglycemia during chemotherapy presents a significant challenge in diabetes management. Disrupted insulin response and increased glucose variability necessitate vigilant monitoring and tailored medication adjustments to reduce complications and support treatment efficacy. . Small steps make a big difference in staying in control.